All News #Library
Lundbeck`s Biologic Vyepti (Eptinezumab) Receives Approval in the U.S.
21 Oct 2022 //
FDA
Lundbeck`s Vyepti (Eptinezumab) Receives Approval in Europe
15 Feb 2022 //
EMA
Lundbeck`s Biological Eptinezumab-Jjmr Receives Supplemental Approval In US
24 Sep 2021 //
FDA
Lundbeck`s Carnexiv (Carbamazepine) Receives Tentative Approval In US
07 Oct 2016 //
FDA

Market Place
Sourcing Support